# Biospecimen Shared Resource

> **NIH NIH P30** · UNIVERSITY OF KANSAS MEDICAL CENTER · 2024 · $182,912

## Abstract

BIOSPECIMEN SHARED RESOURCE: ABSTRACT
The Biospecimen Shared Resource (BSR), led by Andrew K. Godwin, PhD (Founding Director, BSR; Deputy
Director, KUCC, and D3ET member), and by Rashna Madan, MBBS, FCAP, FASCP (Assistant Director,
BSR), plays a vital role in The University of Kansas Cancer Center (KUCC) by its ethical collection, storage,
annotation, and distribution of high-quality human biospecimens, such as fresh/fresh-frozen tumor tissues of
varying histology and bodily fluids (e.g., blood, bone marrow, saliva, urine, ascites fluids), which are essential
to support translational research and investigator-initiated studies. The BSR also provides expert
histopathology support and combines the expertise of pathologists, translational researchers, and technical
personnel to produce a comprehensive and focused approach to support the research activities at KUCC. The
BSR, rated “exceptional to outstanding” in 2017, continues to evolve to meet the ever-expanding and diverse
needs of our KUCC members for highly annotated clinical samples. Additionally, tissue biospecimen collection
is facilitated by pathology assistants, residents and fellows at the KU Hospital and the Indian Creek Campus
(ICC) as part of The University of Kansas Health System’s (TUKHS) commitment to the BSR. The BSR is fully
equipped for biospecimen collection, processing, and distribution, and thus, the BSR adheres to the OSHA
laboratory standards for handling cryogens, ISBER Best Practice for Repositories, and NCI Best Practices for
Biospecimen Resources, and has developed Standard Operating Procedures to govern each of these
processes. The collection, processing, and distribution of specimens by the BSR staff has grown substantially
over the funding period and now includes collections of pediatric specimens from ICC and Children’s Mercy
(CM) and underserved populations from the satellite biospecimen bank at Truman Medical Center (TMC), a
member of the Masonic Cancer Alliance (MCA) and the largest safety-net provider in the Kansas City
Metropolitan area. Since founding the CCSG BSR in 2011, we have enrolled 51,916 consented individuals and
supported the banking of 4,795 participants for investigator-initiated studies resulting in regular usage of de-
identified biospecimens and matching clinical data. During the current grant cycle (2016-2020), the BSR
provided key services in support of 150 publications (57 papers ≥ 10 impact factor), 96 unique cancer center
members, and >35 NIH/NIGMS/NCI grants and contracts including, 1 K01, 1 R00, 12 R01s, 1 R03, 6 R21s, 1
R33, 1 R35, 2 R43, 2 P20, 1 P30, 1 P41, 2 U01, TCGA 13XS194, & CPTAC 14X215, 16x257, 19x139 and 311
clinical trials. In the reporting year (2020), the BRS supported 82 different users (54 KUCC members across all
three programs, of which 85% were funded and 28 non-members, including 16 cancer-focused researchers
nationally). The proposed budget of the BSR (year 11) is $1,511,949, yet the CCSG request is $118,342. As
such, th...

## Key facts

- **NIH application ID:** 10906348
- **Project number:** 5P30CA168524-13
- **Recipient organization:** UNIVERSITY OF KANSAS MEDICAL CENTER
- **Principal Investigator:** ANDREW K. GODWIN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $182,912
- **Award type:** 5
- **Project period:** 2012-07-11 → 2027-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10906348

## Citation

> US National Institutes of Health, RePORTER application 10906348, Biospecimen Shared Resource (5P30CA168524-13). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10906348. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*